Sunday, June 14, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 982 of 1,261

  1. US 7829533

    Cyclosporin analog formulations

    Isotechnika, Inc. · Granted Nov 9, 2010 · Expires Nov 4, 2030

    granted

  2. US 7829503

    Methods of identifying compounds that target tRNA splicing endonuclease and uses of said compounds as anti-fungal agents

    PTC THERAPEUTICS, INC. · Granted Nov 9, 2010 · Expires Nov 4, 2030

    granted

  3. US 7829304

    Compounds and related methods for mutant p53 reactivation

    Northwestern University · Granted Nov 9, 2010 · Expires Nov 4, 2030

    granted

  4. US 7829561

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Nov 9, 2010 · Expires Nov 4, 2030

    granted

  5. US 7829279

    Compositions and methods for diagnosis and treatment of epilepsy

    The Regents of the University of California · Granted Nov 9, 2010 · Expires Nov 4, 2030

    granted

  6. US 7829583

    Biphenyl derivatives

    Theravance, Inc. · Granted Nov 9, 2010 · Expires Nov 4, 2030

    granted

  7. US 7829712

    Pyridazine derivatives for inhibiting human stearoyl-CoA-desaturase

    Xenon Pharmaceuticals Inc. · Granted Nov 9, 2010 · Expires Nov 4, 2030

    granted

  8. US 7829081

    Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases

    HALOZYME, INC. · Granted Nov 9, 2010 · Expires Nov 4, 2030

    granted

  9. US 2010280048

    Some 2-pyrazinone derivatives and their use as inhibitors of neutrophile elastase

    ASTRAZENECA R & D [SE] · Granted Nov 4, 2010 · Expires Oct 30, 2030

    granted

  10. US 2010280081

    ANTI-INFLAMMATORY AGENTS AS VIROSTATIC COMPOUNDS

    4SC AG [DE] · Granted Nov 4, 2010 · Expires Oct 30, 2030

    granted

  11. US 7824690

    Marek's disease virus vaccine

    The United States of America, as represented by the Secretary of Agriculture · Granted Nov 2, 2010 · Expires Oct 28, 2030

    granted

  12. US 7824695

    Delivery of proteins across polar epithelial cell layers

    The United States of America, as represented by the Department of Health and Human Services · Granted Nov 2, 2010 · Expires Oct 28, 2030

    granted

  13. US 7825092

    Dendroaspis natriuretic peptide for treatment of cancer

    United States Department of Veteran Affairs · Granted Nov 2, 2010 · Expires Oct 28, 2030

    granted

  14. US 7825242

    Dipeptidyl peptidase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Nov 2, 2010 · Expires Oct 28, 2030

    granted

  15. US 7825154

    Small molecule inhibitors of botulinum neurotoxins

    The United States of America as represented by the Secretary of the Army · Granted Nov 2, 2010 · Expires Oct 28, 2030

    granted

  16. US 7825102

    Treatment of dry eye conditions

    CAN-FITE BIOPHARMA LTD. · Granted Nov 2, 2010 · Expires Oct 28, 2030

    granted

  17. US 7824680

    Methods for inhibiting angiogenesis

    The Regents of the University of California · Granted Nov 2, 2010 · Expires Oct 28, 2030

    granted

  18. US 7824681

    Human monoclonal antibodies that specifically bind IGF-II

    The United States of America, as represented by the Department of Health and Human Services · Granted Nov 2, 2010 · Expires Oct 28, 2030

    granted

  19. US 7824697

    High concentration baclofen preparations

    The Board of Regents of the University of Texas System · Granted Nov 2, 2010 · Expires Oct 28, 2030

    granted

  20. US 7824682

    Cardiac myosin light chain kinase-specific antibodies and methods of detecting

    The United States of America, as represented by the Department of Health and Human Services · Granted Nov 2, 2010 · Expires Oct 28, 2030

    granted

  21. US 7825126

    Purine derivatives as A3 and A1 adenosine receptor agonists

    The United States of America, as represented by the Department of Health and Human Services · Granted Nov 2, 2010 · Expires Oct 28, 2030

    granted

  22. US 7825278

    Substituted enaminones, their derivatives and uses thereof

    The Regents of the University of California · Granted Nov 2, 2010 · Expires Oct 28, 2030

    granted

  23. US 7825116

    N2, N4-bis-aryl-5-fluoro-2,4-pyrimidinediamines

    Rigel Pharmaceuticals, Inc. · Granted Nov 2, 2010 · Expires Oct 28, 2030

    granted

  24. US 7825096

    O6-alkylguanine-DNA alkyltransferase inactivators and beta-glucuronidase cleavable prodrugs

    The United States of America, as represented by the Department of Health and Human Services · Granted Nov 2, 2010 · Expires Oct 28, 2030

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.